Seeking Alpha

Arena (ARNA -0.7%) rewards the VP of its regulatory affairs, Craig Audet, for his role in the...

Arena (ARNA -0.7%) rewards the VP of its regulatory affairs, Craig Audet, for his role in the company receiving FDA approval for weight-loss drug Belviq by promoting him to Senior VP, Operations and Head of Global Regulatory Affairs. Audet's new role will also include investor relations and alliance management. (PR)
Comments (3)
  • MexCom
    , contributor
    Comments (3058) | Send Message
     
    Leadership and ability is worth more than gold.
    5 Jul 2012, 10:24 AM Reply Like
  • WLNieder
    , contributor
    Comments (4) | Send Message
     
    I looked up his bio and it is outstanding.
    5 Jul 2012, 11:58 AM Reply Like
  • Day Trader001
    , contributor
    Comments (766) | Send Message
     
    "Perfect Choice" !!!!!!
    5 Jul 2012, 03:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs